Navigation Links
Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines
Date:1/29/2010

Increased vaccination could save more than 8 million children by 2020; significant funding gaps remain, others must join effort

DAVOS, Switzerland, Jan. 29 /PRNewswire-USNewswire/ -- Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100129/DC45704)

The Gateses said that increased investment in vaccines by governments and the private sector could help developing countries dramatically reduce child mortality by the end of the decade, and they called for others to help fill critical financing gaps in both research funding and childhood immunization programs.

"We must make this the decade of vaccines," said Bill Gates.  "Vaccines already save and improve millions of lives in developing countries.  Innovation will make it possible to save more children than ever before."

Bill and Melinda Gates made their announcement at the World Economic Forum's Annual Meeting, where they were joined by Julian Lob-Levyt, CEO of the GAVI Alliance.

"Vaccines are a miracle -- with just a few doses, they can prevent deadly diseases for a lifetime," said Melinda Gates.  "We've made vaccines our number-one priority at the Gates Foundation because we've seen firsthand their incredible impact on children's lives."

The foundation used a model developed by a consortium led by the Institute of International Programs at the Johns Hopkins Bloomberg School of Public Health to project the potential impact of vaccines on childhood deaths over the next 10 years.

By significantly scaling up the delivery of life-saving vaccines in developing countries to 90 percent coverage -- including new vaccines to prevent severe diarrhea and pneumonia -- the model suggests that we could prevent the deaths of some 7.6 million children under 5 from 2010-2019. The foundation also estimates that an additional 1.1 million children could be saved with the rapid introduction of a malaria vaccine beginning in 2014, bringing the total number of potential lives saved to 8.7 million.

If additional vaccines are developed and introduced in this decade -- such as for tuberculosis -- even more lives could be saved.

The new funding announced today is in addition to the $4.5 billion that the Gates Foundation has already committed to vaccine research, development and delivery to date across its entire disease portfolio since its inception.

Public-Private Partnerships Drive Progress in Vaccine Development, Delivery

Bill and Melinda Gates said their pledge was inspired by the remarkable progress made on vaccines in recent years.  For example:

  • Record-breaking vaccine access:  New WHO data show that global vaccination rates have reached all-time highs, rebounding from years of decline in the 1990s.  Between 2000 and 2009, the percentage of children receiving the basic DTP3 vaccine in the poorest countries of the world jumped from 66 percent to 79 percent, the highest on record. The number of people who died of measles worldwide fell by 77 percent between 2000 and 2008, and in Africa, measles deaths fell by 92 percent.
  • Improved routine immunization:  Partnerships focused on reducing diseases like polio and measles are also helping build a stronger foundation for the delivery of both new and existing vaccines.  Trained health workers, proper cold chain function, and surveillance are all necessary to ensure vaccines reach every child who needs them.
  • New vaccine introduction:  Important new vaccines for the two leading causes of global child deaths -- severe diarrhea and pneumonia -- are becoming available.  Research published this week in The New England Journal of Medicine shows that introducing a rotavirus vaccine in South Africa and Malawi reduced severe diarrhea caused by the virus by more than 60 percent.
  • R&D momentum:  The vaccine research and development pipeline is more robust than ever.  Late-stage trials have begun on a promising vaccine to protect children from malaria, and a new vaccine to prevent meningitis outbreaks in Africa is likely to be introduced this year.

Many of the recent advances in vaccine development and delivery have been driven by public-private partnerships such as the GAVI Alliance and the Rotavirus Vaccine Program at PATH, which coordinate the resources and expertise of vaccine companies, donors, UNICEF, WHO, the World Bank, and developing countries.  Mr. Gates said these partnerships are "transforming the business of vaccines."

The GAVI Alliance -- launched at the World Economic Forum 10 years ago this week -- has reached 257 million additional children with new and underused vaccines, and prevented 5 million future deaths.  In the coming years, GAVI will focus on rapidly introducing vaccines to tackle diarrhea and pneumonia.

"Investments in global immunization have yielded an extraordinary return," said Julian Lob-Levyt.  "The GAVI Alliance was founded just 10 years ago and has already saved 5 million lives by increasing access to immunization in the world's poorest countries. The potential to make bigger strides in the coming decade is even more exciting."

Increased Commitments Critical to Future Success

Today's commitment will support a broad spectrum of vaccine-related activities, from basic research to innovations in delivery. However, billions more are needed from other donors to achieve the goal of 90 percent coverage of childhood immunization. Critical funding gaps exist at GAVI and in the global polio and measles programs, and more support is needed for the research and development necessary to produce new vaccines.

Speakers at the press conference underscored the need for major new funding from donors, governments and the private sector to:

  • Rapidly scale immunization programs in order to reach all those in need
  • Conduct the laboratory research and clinical trials needed to create new vaccines
  • Introduce life-saving new vaccines for pneumonia and severe diarrhea, as well as other promising vaccines currently in the development pipeline
  • Ensure a steady market for vaccines in developing countries, and an adequate supply from manufacturers

Commenting on the announcement, WHO Director-General Margaret Chan said, "The Gates Foundation's commitment to vaccines is unprecedented, but just a small part of what is needed. It's absolutely crucial that both governments and the private sector step up efforts to provide life-saving vaccines to children who need them most."

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives.  In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty.  In the United States, it seeks to ensure that all people, especially those with the fewest resources, have access to the opportunities they need to succeed in school and life.  Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

NOTE TO EDITORS:

Live webcast and replay will be available at http://www.livestream.com/worldeconomicforum

Video replay will be also be available at http://www.livestream.com/worldeconomicforum/videos

Multimedia:  To access various video clips, B-roll, still photos and other available resources, you may go to the foundation's Newsmarket link http://www.gatesfoundation.org/press-room/Pages/news-market.aspx  and click on "multimedia presspacks."

SOURCE Bill & Melinda Gates Foundation

RELATED LINKS
http://www.gatesfoundation.org

'/>"/>

SOURCE Bill & Melinda Gates Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
2. Ionian Technologies, Inc. Receives Additional Funding from the Bill & Melinda Gates Foundation to Develop Point-of-Care Diagnostic Tests for the Developing World
3. AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa
4. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
5. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
6. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
7. Gates Foundation Seeks Proposals for Innovative Global Health Research
8. Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees
9. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
10. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
11. Dominos Pizza Pledges Support to the Fifth Annual St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... national conference convening academic faculty engaged in or interested in palliative care education and ... will be held in North County San Diego on Sept. 28 and 29, ...
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... official 2017 partnership with The Jensie Gran Fondo of Marin. For the second ... rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
Breaking Medicine News(10 mins):